Poland· PL-100511746
Concoram
A bisoprolol und amlodipin product containing bisoprololi fumaras + amlodipinum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Bisoprolol und amlodipin is registered in 2 of 19 countries.
Countries holding a registration under ATC C07FB07 (bisoprolol und amlodipin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Bisoprolol und amlodipin · ATC C07FB07
2 / 19 countries
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Bisoprololi fumaras + Amlodipinum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C07FB07
- ATC class
- Bisoprolol und Amlodipin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991562953
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bisoprolol und amlodipin in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBIGITALEgis Pharmaceuticals PLC, Budapešť
- GermanyBiramloApontis Pharma Deutschland Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Concor Amlo
- Bulgaria · Алотендин, Конкор Ам
- Cyprus · Amoduo
- Czechia · Bigital, Concor Combi
- Germany · Biramlo, Bisodipin
- Estonia · Sobycombi
- Greece · Amoduo
- Croatia · Concor Am
- Hungary · Concor Amlo, Opimol
- Italy · Congexam
- Lithuania · Alotendin
- Latvia · Alotendin, Concor Am
- Romania · Alotendin, Concor Am
- Slovenia · Bisoprolol/Amlodipin Krka
- Slovakia · Bigital, Concor Combi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad3aae39-4603-4467-98e1-cd08137f2806 GET /v1/drugs/ad3aae39-4603-4467-98e1-cd08137f2806?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "5 mg + 10 mg",
"packaging": "05909991562953 ¦ Rp ¦ 159910\n30 tabl.",
"substance": "Bisoprololi fumaras 5 mg + Amlodipinum 10 mg",
"common_name": "Bisoprololi fumaras + Amlodipinum",
"pl_product_id": "100511746",
"pozwolenie_nr": "014/25",
"auth_procedure": "IR",
"authorisation_validity": "2030-01-15"
}See everything about bisoprolol und amlodipin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.